Genetix's Drug Discovery Division will join Molecular Devices, a provider of instruments, software, and consumables for drug discovery and life sciences research.
Genetix offers cell selection and cell imaging instrumentation and related products to basic and applied research scientists.
Genetix’s ClonePix and QPix instrument platforms address cell lines used in biotherapeutic research.
ClonePix is an automated mammalian cell selection platform that expedites the process of identifying and selecting cells that produce biotherapeutic candidates.
In addition, Genetix’s CloneSelect Imager and CellReporter will extend Molecular Devices’ imaging portfolio.
Molecular Devices president Mark Verheyden said they are excited about welcoming Genetix into the Molecular Devices team, knowing that the combined business will better positioned to serve their customers.
Molecular Devices offers spectrum of detection technologies and meet needs of single-readout devices to multi-readout systems.